Svelte Medical Systems Announces Final Patient Treated in the DIRECT Drug-Eluting Stent Study May 15, 2012 New Providence, NJ – Svelte® Medical Systems today announced completion of enrollment in the DIRECT (Direct Im - substantial equivalence - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2012-08-16 08:57:13 Immunosuppressants Macrolides Drug-eluting stent Medical equipment Stent Restenosis Sirolimus Cardiology Biosensors International Medicine Implants Interventional cardiology		Svelte Medical Systems Announces Final Patient Treated in the DIRECT Drug-Eluting Stent Study May 15, 2012 New Providence, NJ – Svelte® Medical Systems today announced completion of enrollment in the DIRECT (Direct Im Add to Reading List Source URL: www.apjohnventures.com Download Document from Source Website File Size: 33,70 KB Share Document on Facebook

	Advanced Cardiovascular Stent Incorporated with a Nitric Oxide Delivery System Investigators: Hai-Lung Tsai (, ), Adam Hamdorf, Cheng-Hsiang Lin, Patrick Margavio, Chi H Lee (UMKC), Richard Hopki DocID: 1qd5n - View Document
	COMPUTATIONAL STUDY OF THE FLUID-DYNAMICS IN CAROTIDS BEFORE AND AFTER ENDARTERECTOMY Bruno Guerciotti MOX, Dipartimento di Matematica, Politecnico di Milano, Italy DocID: 1pIIl - View Document
	Endovascular management of spontaneous carotid artery dissection Randall C. Edgell, MD,a Alex Abou-Chebl, MD,a and Jay S. Yadav, MD,b Cleveland, Ohio Objective: Despite medical therapy, a subset of patients with spontane DocID: 1oTg6 - View Document
	MSC PARTNER: SPECTRANETICS BELIEVES THAT TRAINING MAKES THE DIFFERENCE and achieves big results that prove it. DocID: 1mCum - View Document
	Vascular Brachytherapy for In-stent Restenosis Beta-Cath™ DocID: 1ggwq - View Document